{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T22:10:01Z","timestamp":1739311801937,"version":"3.37.0"},"reference-count":53,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2009,8,26]],"date-time":"2009-08-26T00:00:00Z","timestamp":1251244800000},"content-version":"vor","delay-in-days":3940,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Fundamemntal Clinical Pharma"],"published-print":{"date-parts":[[1998,11,12]]},"abstract":"<jats:p><jats:bold>Summary\u2014<\/jats:bold>To assess the role of spinal dopamine receptors in mediation of hypotension induced by systemic administration of the dopamine D<jats:sub>2<\/jats:sub>receptor agonist, bromocriptine, conscious deoxycorticosterone acetate (DOCA)\u2010salt hypertensive rats were pretreated with either intravenous (iv; 500 \u03bcg\/kg) or intrathecal (it; 40 \u03bcg\/rat at T<jats:sub>9<\/jats:sub>\u2010T<jats:sub>10<\/jats:sub>) domperidone, a selective dopamine D<jats:sub>2<\/jats:sub>receptor antagonist that does not cross the blood\u2010brain barrier. In DOCA\u2010salt hypertensive rats, iv administration of a sub\u2010maximal dose of bromocriptine (150 \u03bcg\/kg) induced a significant decrease in mean aortic pressure (MAP) which was greater and longer lasting than that in uninephrectomized control rats. Intravenous or it pretreatment with domperidone reduced partially, but significantly, the hypotensive effect of bromocriptine (reduction of about 57% and 45% of the maximal effect, respectively). The remaining responses observed during the 60 min postinjection period were still statistically significant as compared with vehicle injection. In contrast, the bromocriptine\u2010induced hypotension was fully abolished by iv pretreatment with metoclopramide (300 \u03bcg\/kg), a dopamine D<jats:sub>2<\/jats:sub>receptor antagonist that crosses the blood\u2010brain barrier, or by combined pretreatment with iv and it domperidone. These results suggest that, in DOCA\u2010salt hypertensive rats, the hypotension induced by iv bromocriptine is mediated partly through a peripheral D<jats:sub>2<\/jats:sub>dopaminergic mechanism and partly through stimulation of spinal dopamine D<jats:sub>2<\/jats:sub>receptors, as has been demonstrated in conscious normotensive rats.<\/jats:p>","DOI":"10.1111\/j.1472-8206.1998.tb00992.x","type":"journal-article","created":{"date-parts":[[2009,8,26]],"date-time":"2009-08-26T17:31:07Z","timestamp":1251307867000},"page":"599-606","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Hypotensive action of bromocriptine in the DOCA\u2010salt hypertensive rat: Contribution of spinal dopamine receptors"],"prefix":"10.1111","volume":"12","author":[{"given":"S","family":"Lahlou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G Pinto","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,8,26]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-39-2-391"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.26.5.405"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)92832-X"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.2.4.390"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.35.11.1644"},{"key":"e_1_2_1_7_2","first-page":"509","article-title":"Metoclopramide blocks bromocriptine induced antihypertensive effect in hypertensive patients","volume":"33","author":"Luchsinger A","year":"1995","journal-title":"Int J Clin Pharmacol Ther"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1981.tb10992.x"},{"key":"e_1_2_1_9_2","first-page":"93","article-title":"Cardiovascular effects of bromocriptine and lergotrile in renal and spontaneously hypertensive rats","volume":"266","author":"Tadepalli AS","year":"1983","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"e_1_2_1_10_2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0022-3565(25)21708-6","article-title":"Mechanism of the depressor effect of bromocriptine in the spontaneously hypertensive rat","volume":"228","author":"Nagahama S","year":"1984","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_11_2","first-page":"676","article-title":"Bromocriptine decreases blood pressure in spontaneously hypertensive rats without affecting the adrenomedullary synthesis of catecholamines","volume":"8","author":"Racz K","year":"1986","journal-title":"J Cardiovasc Pharmacol"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1989.tb06549.x"},{"key":"e_1_2_1_13_2","first-page":"H64","article-title":"Enhanced depressor effect of bromocriptine in the DOCA\/NaCl hypertensive rat","volume":"249","author":"Nagahama S","year":"1985","journal-title":"Am J Physiol"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1474-8673.1990.tb00008.x"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199109000-00003"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199205000-00010"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/27.11.2022"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(79)90178-X"},{"key":"e_1_2_1_19_2","first-page":"183","article-title":"The role of the adrenal medulla in the antihypertensive action of bromocriptine in neurogenic hypertensive dogs","volume":"14","author":"Montastruc JL","year":"1983","journal-title":"J Pharmacol (Paris)"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(79)90198-9"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(80)90203-9"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(83)90618-0"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-3623(88)90153-X"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.1979.tb06491.x"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0361-9230(82)90136-8"},{"key":"e_1_2_1_26_2","first-page":"523","article-title":"Le syst\u00e8me dopaminergique spinal","volume":"17","author":"Mouchet P","year":"1986","journal-title":"J Pharmacol (Paris)"},{"key":"e_1_2_1_27_2","first-page":"529","volume-title":"Progress in Catecholamine Research, Part B: Central Aspects","author":"Feuerstein C","year":"1988"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1981.tb05290.x"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(86)90010-2"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.1996.tb01247.x"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(84)90632-0"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199008000-00021"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199110000-00011"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/27.2.222"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(84)90666-8"},{"key":"e_1_2_1_36_2","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0022-3565(25)23603-5","article-title":"Mechanism of the depressor action of LY171555, a selective dopamine D2 receptor agonist, in the anesthetized rat","volume":"239","author":"Nagahama S","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-8206.1987.tb00557.x"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-8206.1992.tb00096.x"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(76)90056-3"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(82)90165-5"},{"key":"e_1_2_1_41_2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0022-3565(25)22677-5","article-title":"Pharmacological characterization of spinal alpha adrenoceptors related to blood pressure control in rats","volume":"240","author":"Kubo T","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-1716.1990.tb08820.x"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.1978.tb13238.x"},{"key":"e_1_2_1_44_2","first-page":"20","article-title":"Comparative analysis of presynaptic inhibition of noradrenaline release by alpha\u20102 and dopamine receptors","volume":"49","author":"Langer SZ.","year":"1981","journal-title":"Acta Pharmacol Toxicol"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(82)90078-9"},{"key":"e_1_2_1_46_2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0031-6997(25)06824-3","article-title":"Neuronal dopamine receptors on autonomic ganglia and sympathetic nerves and dopamine receptors in the gastrointestinal system","volume":"37","author":"Willems JL","year":"1985","journal-title":"Pharmacol Rev"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-88-5-671"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1474-8673.1985.tb00552.x"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.3109\/10641968709161458"},{"key":"e_1_2_1_50_2","first-page":"1071","article-title":"Differential effects of the selective dopamine (DA) agonist, quinpirole, on blood pressure in conscious normotensive and hypertensive rats.","volume":"45","author":"Kurz K","year":"1986","journal-title":"Fed Proc"},{"key":"e_1_2_1_51_2","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0022-3565(25)38932-9","article-title":"Mechanism of the pressor action of LY171555, a specific dopamine D2 receptor agonist, in the conscious rat","volume":"236","author":"Nagahama S","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_52_2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0022-3565(25)39044-0","article-title":"Role of vasopressin in the cardiovascular effects of LY171555, a selective dopamine D2 receptor agonist: studies in conscious Brattleboro and Long\u2010Evans rats","volume":"242","author":"Nagahama S","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_53_2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0022-3565(25)22083-3","article-title":"Blunted pressor responsiveness to quinpirole, a specific dopamine D2 receptor agonist, in conscious deoxycorticosterone acetate\/NaCl hypertensive rats is related to atrial natriuretic peptide release","volume":"246","author":"Chen YF","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(73)90302-8"}],"container-title":["Fundamental &amp; Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1472-8206.1998.tb00992.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1472-8206.1998.tb00992.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T21:32:53Z","timestamp":1739309573000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1472-8206.1998.tb00992.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,11,12]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1998,11,12]]}},"alternative-id":["10.1111\/j.1472-8206.1998.tb00992.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1472-8206.1998.tb00992.x","archive":["Portico"],"relation":{},"ISSN":["0767-3981","1472-8206"],"issn-type":[{"type":"print","value":"0767-3981"},{"type":"electronic","value":"1472-8206"}],"subject":[],"published":{"date-parts":[[1998,11,12]]},"assertion":[{"value":"2009-08-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}